- Home
- Publications
- Publication Search
- Publication Details
Title
APOA1: a Protein with Multiple Therapeutic Functions
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume 23, Issue 3, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-19
DOI
10.1007/s11883-021-00906-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
- (2020) Gregory G. Schwartz et al. DIABETES CARE
- HDL inhibits endoplasmic reticulum stress-induced apoptosis of pancreatic β-cells in vitro by activation of Smoothened
- (2020) Mustafa Yalcinkaya et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice
- (2020) Kristine C. McGrath et al. PLoS One
- ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα2
- (2020) Andreas Mæchel Fritzen et al. Molecular Metabolism
- Apolipoprotein A-I anti-tumor activity targets cancer cell metabolism
- (2020) Maryam Zamanian-Daryoush et al. Oncotarget
- Apolipoprotein A-I enhances activated protein C cytoprotective activity
- (2020) Eimear M. Gleeson et al. Blood Advances
- Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle
- (2019) Shudi Tang et al. Scientific Reports
- ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
- (2019) Shelley J. Edmunds et al. DIABETOLOGIA
- Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1
- (2019) Liming Hou et al. FASEB JOURNAL
- Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis
- (2019) Andrew L. Zhou et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux
- (2019) Tao Zhang et al. Journal of Translational Medicine
- ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
- (2019) Emily B. Button et al. Alzheimers Research & Therapy
- The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro
- (2019) Roberta Dal Magro et al. Frontiers in Neuroscience
- Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
- (2019) Georgila et al. Cancers
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Apolipoprotein A-I primes beta cells to increase glucose stimulated insulin secretion
- (2019) Oktawia Nilsson et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation
- (2019) Tessa J. Barrett et al. CIRCULATION
- Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques
- (2019) Panagiotis Fotakis et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner
- (2018) Kristina K. Durham et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages
- (2018) Min Zhang et al. CIRCULATION JOURNAL
- HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway
- (2018) Dimitris Theofilatos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis
- (2018) Dalia E. Gaddis et al. Nature Communications
- High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation
- (2018) Massimiliano Ruscica et al. Scientific Reports
- Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer
- (2018) Arnab Chattopadhyay et al. Scientific Reports
- Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial
- (2018) Stephen J. Nicholls et al. JAMA Cardiology
- Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial
- (2018) Stephen J. Nicholls et al. JAMA Cardiology
- 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
- (2018) Sandeep R. Das et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Possible Insulinotropic Action of Apolipoprotein A–I Through the ABCA1/Cdc42/cAMP/PKA Pathway in MIN6 Cells
- (2018) Koki Matsumura et al. Frontiers in Endocrinology
- Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Low apoA-I is associated with insulin resistance in patients with impaired glucose tolerance: a cross-sectional study
- (2017) Xiaomeng Feng et al. Lipids in Health and Disease
- Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease
- (2017) Sofía Fernández-de Retana et al. NEUROBIOLOGY OF AGING
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis
- (2017) Qi Quan et al. Translational Oncology
- Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression
- (2017) Meiyu Peng et al. Oncotarget
- Apolipoprotein A‐I Modulates Atherosclerosis Through Lymphatic Vessel‐Dependent Mechanisms in Mice
- (2017) Andreea Milasan et al. Journal of the American Heart Association
- Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of AtherosclerosisHighlights
- (2016) Bradley K. Wacker et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells
- (2016) Bing Pan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice
- (2016) Jérôme Robert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma
- (2016) Xue-Ping Wang et al. BMC CANCER
- Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
- (2016) C. Michael Gibson et al. CIRCULATION
- Dual Actions of Apolipoprotein A-I on Glucose-Stimulated Insulin Secretion and Insulin-Independent Peripheral Tissue Glucose Uptake Lead to Increased Heart and Skeletal Muscle Glucose Disposal
- (2016) Joan Domingo-Espín et al. DIABETES
- In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes
- (2016) Blake J. Cochran et al. DIABETOLOGIA
- Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity
- (2016) Donna Lee M. Dinnes et al. FASEB JOURNAL
- Apolipoproteins, lipids and risk of cancer
- (2016) Signe Borgquist et al. INTERNATIONAL JOURNAL OF CANCER
- Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
- (2016) Cristina Merino-Zamorano et al. JOURNAL OF ALZHEIMERS DISEASE
- Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages
- (2016) Chongren Tang et al. JOURNAL OF LIPID RESEARCH
- ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
- (2016) Lídia Cedó et al. Scientific Reports
- Lipid‐Free Apolipoprotein A‐I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio
- (2016) Sushma Kaul et al. Journal of the American Heart Association
- Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory PropertiesSignificance
- (2015) Su Duy Nguyen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion
- (2015) D. W. Chung et al. BLOOD
- Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis
- (2015) K K Gkouskou et al. ONCOGENE
- Apolipoprotein A-I and Cancer
- (2015) Maryam Zamanian-Daryoush et al. Frontiers in Pharmacology
- Apolipoprotein A-I Increases Insulin Secretion and Production From Pancreatic β-Cells via a G-Protein-cAMP-PKA-FoxO1–Dependent Mechanism
- (2014) Blake J. Cochran et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-density lipoprotein as a modulator of platelet and coagulation responses
- (2014) M. van der Stoep et al. CARDIOVASCULAR RESEARCH
- Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice
- (2014) Karin G. Stenkula et al. DIABETOLOGIA
- Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk
- (2014) Mathilde His et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- High-Density Lipoprotein Maintains Skeletal Muscle Function by Modulating Cellular Respiration in Mice
- (2013) Maarit Lehti et al. CIRCULATION
- Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice
- (2013) Catherine Martel et al. JOURNAL OF CLINICAL INVESTIGATION
- High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3
- (2013) Dominic De Nardo et al. NATURE IMMUNOLOGY
- Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis
- (2013) Andrew J Murphy et al. NATURE MEDICINE
- Extrahepatic High-Density Lipoprotein Receptor SR-BI and ApoA-I Protect Against Deep Vein Thrombosis in Mice
- (2012) Alexander Brill et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesterol Efflux and Atheroprotection
- (2012) Robert S. Rosenson et al. CIRCULATION
- High-Density Lipoproteins Inhibit Vascular Endothelial Inflammation by Increasing 3β-Hydroxysteroid-Δ24 Reductase Expression and Inducing Heme Oxygenase-1
- (2012) Ben J. Wu et al. CIRCULATION RESEARCH
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A 1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
- (2011) Philip J. Barter et al. CIRCULATION
- L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways
- (2011) Feng Gao et al. Integrative Biology
- Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion
- (2010) Michelle A. Fryirs et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Myeloid Differentiation Primary Response Protein 88 Couples Reverse Cholesterol Transport to Inflammation
- (2010) Kathleen A. Smoak et al. Cell Metabolism
- Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
- (2010) Terry L. Lewis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Baseline and On-Treatment High-Density Lipoprotein Cholesterol and the Risk of Cancer in Randomized Controlled Trials of Lipid-Altering Therapy
- (2010) Haseeb Jafri et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
- (2010) F. Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of 3β-Hydroxysteroid-Δ24 Reductase in Mediating Antiinflammatory Effects of High-Density Lipoproteins in Endothelial Cells
- (2009) K.C.Y. McGrath et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- L-4F Alters Hyperlipidemic (But Not Healthy) Mouse Plasma to Reduce Platelet Aggregation
- (2009) Georgette M. Buga et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
- (2009) Brian G. Drew et al. CIRCULATION
- Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells
- (2009) Sabine Rütti et al. ENDOCRINOLOGY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now